- Home
- DLTH vs IPSC Comparison
DLTH vs IPSC Comparison
Compare DLTH & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLTH
- IPSC
- Stock Information
- Founded
- DLTH 1989
- IPSC 2019
- Country
- DLTH United States
- IPSC United States
- Employees
- DLTH N/A
- IPSC N/A
- Industry
- DLTH Clothing/Shoe/Accessory Stores
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- DLTH Consumer Discretionary
- IPSC Health Care
- Exchange
- DLTH Nasdaq
- IPSC Nasdaq
- Market Cap
- DLTH 62.6M
- IPSC 58.1M
- IPO Year
- DLTH 2015
- IPSC 2021
- Fundamental
- Price
- DLTH $1.88
- IPSC $0.54
- Analyst Decision
- DLTH Hold
- IPSC Strong Buy
- Analyst Count
- DLTH 1
- IPSC 5
- Target Price
- DLTH $2.75
- IPSC $3.67
- AVG Volume (30 Days)
- DLTH 37.9K
- IPSC 735.0K
- Earning Date
- DLTH 05-29-2025
- IPSC 05-20-2025
- Dividend Yield
- DLTH N/A
- IPSC N/A
- EPS Growth
- DLTH N/A
- IPSC N/A
- EPS
- DLTH N/A
- IPSC N/A
- Revenue
- DLTH $626,629,000.00
- IPSC $6,589,000.00
- Revenue This Year
- DLTH N/A
- IPSC $833.10
- Revenue Next Year
- DLTH N/A
- IPSC N/A
- P/E Ratio
- DLTH N/A
- IPSC N/A
- Revenue Growth
- DLTH N/A
- IPSC 194.81
- 52 Week Low
- DLTH $1.58
- IPSC $0.34
- 52 Week High
- DLTH $4.54
- IPSC $3.47
- Technical
- Relative Strength Index (RSI)
- DLTH 50.46
- IPSC 51.91
- Support Level
- DLTH $1.71
- IPSC $0.52
- Resistance Level
- DLTH $1.96
- IPSC $0.57
- Average True Range (ATR)
- DLTH 0.13
- IPSC 0.03
- MACD
- DLTH 0.03
- IPSC 0.00
- Stochastic Oscillator
- DLTH 64.71
- IPSC 58.75
About DLTH Duluth Holdings Inc. Class B
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.